UBIQUITINATED INCLUSIONS IN INCLUSION-BODY MYOSITIS PATIENTS ARE IMMUNOREACTIVE FOR CATHEPSIN-D BUT NOT BETA-AMYLOID

Citation
Fe. Sherriff et al., UBIQUITINATED INCLUSIONS IN INCLUSION-BODY MYOSITIS PATIENTS ARE IMMUNOREACTIVE FOR CATHEPSIN-D BUT NOT BETA-AMYLOID, Neuroscience letters, 194(1-2), 1995, pp. 37-40
Citations number
33
Categorie Soggetti
Neurosciences
Journal title
ISSN journal
03043940
Volume
194
Issue
1-2
Year of publication
1995
Pages
37 - 40
Database
ISI
SICI code
0304-3940(1995)194:1-2<37:UIIIMP>2.0.ZU;2-R
Abstract
The nature of the inclusions in the human muscle disease inclusion-bod y myositis (IBM) has been the subject of debate. Parallels with Alzhei mer's disease have been drawn after these inclusions were found to be ubiquitinated, and immunoreactive with antibodies to beta-amyloid (alp ha beta) and certain amyloid-associated proteins. We have used a batte ry of antibodies against alpha beta and associated proteins to immunos tain muscle biopsies from patients with IBM. Although the inclusions a re ubiquitinated, we could not show immunoreactivity for alpha beta or the associated proteins investigated. We did, however, find that the ubiquitinated inclusions colocalised with the lysosomal marker, cathep sin D.